摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-[[[3-甲基-1-氧代-4-(2,2,2-三氟乙氧基)-2-吡啶基]甲基]亚磺酰基]-1H-苯并咪唑 | 213476-12-1

中文名称
2-[[[3-甲基-1-氧代-4-(2,2,2-三氟乙氧基)-2-吡啶基]甲基]亚磺酰基]-1H-苯并咪唑
中文别名
2-[[[3-甲基-1-氧代-4-(2,2,2-三氟乙氧基)-2-吡啶]甲基]亚硫酰基]苯并咪唑;右旋兰索拉唑杂质A;右旋兰索拉唑
英文名称
lansoprazole N-oxide
英文别名
2-[[3-methyl-1-oxido-4-(2,2,2-trifluoroethoxy)pyridin-1-ium-2-yl]methylsulfinyl]-1H-benzimidazole
2-[[[3-甲基-1-氧代-4-(2,2,2-三氟乙氧基)-2-吡啶基]甲基]亚磺酰基]-1H-苯并咪唑化学式
CAS
213476-12-1
化学式
C16H14F3N3O3S
mdl
——
分子量
385.367
InChiKey
OBGHBYDDJGHGNS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    163-165°C (dec.)
  • 沸点:
    657.4±65.0 °C(Predicted)
  • 密度:
    1.53±0.1 g/cm3 (20 ºC 760 Torr)
  • 溶解度:
    可溶于DMSO(少许)、甲醇(少许)

计算性质

  • 辛醇/水分配系数(LogP):
    2
  • 重原子数:
    26
  • 可旋转键数:
    5
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    99.6
  • 氢给体数:
    1
  • 氢受体数:
    8

SDS

SDS:930fdf2ca66a043776940faf6578fc33
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    兰索拉唑硫醚N-氧化物间氯过氧苯甲酸 作用下, 以 氯仿 为溶剂, 反应 0.5h, 以67%的产率得到2-[[[3-甲基-1-氧代-4-(2,2,2-三氟乙氧基)-2-吡啶基]甲基]亚磺酰基]-1H-苯并咪唑
    参考文献:
    名称:
    Synthesis and Characterization of Metabolites and Potential Impurities of Lansoprazole, an Antiulcerative Drug
    摘要:
    Lansoprazole (Prevacid) is an antiulcerative drug used for the treatment of duodenal and gastric ulcers, reflux oesophagitis, and Zollinger-Ellison syndrome. During the bulk synthesis of lansoprazole, we have observed five impurities: lansoprazole N-oxide, lansoprazole sulfone N-oxide, lansoprazole sulfide, lansoprazole sulfone and N-aralkyl lansoprazole. The present work describes the synthesis and characterization of these impurities.
    DOI:
    10.1080/00397910802162934
点击查看最新优质反应信息

文献信息

  • Method for preparing 2- (2-pyridinylmethylsulfinyl) benzimidazoles
    申请人:Fan Chin-Tsai
    公开号:US20090005570A1
    公开(公告)日:2009-01-01
    The present invention provides a method for preparing an antiulcer agent, 2-(2-pyridinylmethylsulfinyl)benzimidazoles, such as Omeprazole, Lansoprazole, Pantoprazole and Rabeprazole, which includes oxidizing an intermediate having a linkage of methylthio group (—CH 2 S—) to methylsulfinyl (—CH 2 S(O)—) in the presence of an oxidation catalyst of an alkali metal salt of tungstate at a temperature of 10-50° C.
    本发明提供了一种制备抗溃疡剂2-(2-吡啶甲基磺酰基)苯并咪唑类化合物,例如奥美拉唑、兰索拉唑、泮托拉唑和雷贝拉唑的方法,其中包括在碱金属钨酸盐氧化催化剂的存在下,在10-50°C的温度下将具有甲硫基链(-CH2S-)的中间体氧化为甲基磺酰基链(-CH2S(O)-)。
  • ORAL SOLID PREPARATION COMPOSITION COMPRISING PROTON PUMP INHIBITOR, ORAL SOLID PREPARATION COMPRISING SAME, AND PREPARATION METHOD THEREFOR
    申请人:LOTTE Fine Chemical Co., Ltd.
    公开号:EP3646855A2
    公开(公告)日:2020-05-06
    Provided are an oral solid preparation composition, including a proton pump inhibitor or a pharmaceutically acceptable salt thereof; and a binding liquid including a basic additive, wherein a content of the basic additive is 2 to 13 parts by weight based on 100 parts by weight of the proton pump inhibitor or a pharmaceutically acceptable salt thereof; an oral solid preparation including the same; and a method of preparing the same. According to the present disclosure, an oral solid preparation exhibiting a significant reduction in the production of related substances and excellent stability against moisture and low pH is provided.
    本发明提供了一种口服固体制剂组合物,包括质子泵抑制剂或其药学上可接受的盐;以及一种包括碱性添加剂的结合液,其中碱性添加剂的含量以100份重量的质子泵抑制剂或其药学上可接受的盐为基准,为2至13份重量;包括该组合物的口服固体制剂;以及制备该组合物的方法。根据本公开,提供了一种口服固体制剂,该制剂显著减少了相关物质的产生,并具有优异的防潮稳定性和低 pH 值稳定性。
  • Efficient Synthesis of <i>N</i>‐Oxide Derivatives: Substituted 2‐(2‐(Pyridyl‐<i>N</i>‐oxide)methylsulphinyl)benzimidazoles
    作者:Purna C. Ray、Vasantha Mittapelli、Amit Rohatgi、Om Dutt Tyagi
    DOI:10.1080/00397910701470693
    日期:2007.8.1
  • US7531666B2
    申请人:——
    公开号:US7531666B2
    公开(公告)日:2009-05-12
  • [EN] ORAL SOLID PREPARATION COMPOSITION COMPRISING PROTON PUMP INHIBITOR, ORAL SOLID PREPARATION COMPRISING SAME, AND PREPARATION METHOD THEREFOR<br/>[FR] COMPOSITION POUR PRÉPARATION SOLIDE À USAGE ORAL COMPRENANT UN INHIBITEUR DE POMPE À PROTONS, PRÉPARATION SOLIDE À USAGE ORAL LA COMPRENANT, ET SON PROCÉDÉ DE PRÉPARATION<br/>[KO] 프로톤 펌프 저해제를 포함하는 경구용 고형제제 조성물, 이를 포함하는 경구용 고형제제 및 그 제조방법
    申请人:LOTTE FINE CHEMICAL CO LTD
    公开号:WO2019004770A2
    公开(公告)日:2019-01-03
    본 발명은 프로톤 펌프 저해제 또는 이의 약학적으로 허용 가능한 염; 및 염기성 첨가제를 포함하는 결합액;을 포함하되, 상기 염기성 첨가제의 함량은 상기 프로톤 펌프 저해제 또는 이의 약학적으로 허용 가능한 염 100중량부를 기준으로 2 ~ 13중량부인 것을 특징으로 하는 경구용 고형제제 조성물 및 이를 경구용 고형제제 및 그 제조방법에 관한 것이다. 본 발명에 따르면, 유연물질 생성이 현저히 감소되면서 수분 및 낮은 pH에 대한 안정성이 우수한 경구용 고형제제를 제공할 수 있다.
查看更多